Institut Claudius Regaud: all 117 studies
Page 2 of 2. Open to participants first (34), then studies with results posted, then the rest; newest registration first within each.
- Pharmacology of Adjuvant Hormonotherapy in Breast CancerCompletedNCT01127295Phase 4
- Cilengitide Together With Radiochemotherapy in Patients With Locally Advanced Non Small Cell Lung CancerCompletedNCT01118676Phase 1
- Adipose Tissue Transfer for Moderate Breast Cancer Conservative Treatment SequellaTerminatedNCT01035268Phase 3
- Exemestane (Aromasine) + Tamoxifen - Breast Neo-AdjuvantCompletedNCT00919399Phase 2
- Observation Versus Post-surgery Radiotherapy After Complete Exeresis in Soft Tissues Members SarcomaTerminatedNCT00870701Phase 3
- Dose Intensification Study in Refractory Germ Cell Tumors With Relapse and Bad PrognosisCompletedNCT00864318Phase 2
- Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the BrainCompletedNCT00814021Phase 2
- Vorinostat in Combination With Vinorelbine in Patients With Advanced CancerTerminatedNCT00801151Phase 1
- Kidney Damage in Patients Receiving Cisplatin and Ifosfamide for Solid TumorsSuspendedNCT00695032Not applicable
- Phase 3 Study of Acupression's Bracelets in Nausea and Vomiting Induced by FEC100 Chemotherapy's Sort.CompletedNCT00268125Phase 3
- Prospective and Randomized Study to Evaluate Interest of Ultracision Use in Inguinal Lymph Nodes CurageCompletedNCT00224744Phase 3
- Phase 2 Study of Association Gemcitabine-Cisplatin to Treat Penis Epidermoid CarcinomaCompletedNCT00210041Phase 2
- Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast CancerTerminatedNCT00210028Phase 2
- Evaluation of Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of Severe Anaemia Chemo-InducedTerminatedNCT00210002Phase 2
- Phase II Trial to Assess the Radiosensitizing Effect of ZARNESTRA in Patients With Glioblastoma MultiformeCompletedNCT00209989Phase 2
- Determination of Carboplatin's Optimal Plasmatic ExposureCompletedNCT00145028Not applicable
- Study of Biological Effect of Tarceva (OSI-774) for Patients Stricken by ENT Epidermoid CarcinomaCompletedNCT00144976Not applicable